Welcome to our dedicated page for Abri Spac I news (Ticker: ASPAW), a resource for investors and traders seeking the latest updates and insights on Abri Spac I stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Abri Spac I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Abri Spac I's position in the market.
Summary not available.
Abri SPAC I, Inc. (NASDAQ: ASPA, ASPAW, ASPAU) announced that stockholders can reverse their redemption requests until 5:00 PM ET on December 9, 2022. The company will extend its initial business combination deadline from February 12, 2023, to August 12, 2023, through a $525,000 trust account contribution. At the special meeting, stockholders requested to redeem 4,931,548 shares, with approximately $10.20 per share available. Abri's merger with DLQ, Inc. is expected to close soon, allowing the combined entity to continue NASDAQ trading under the name DataLogiq, Inc.